1. Home
  2. MTSI vs ILMN Comparison

MTSI vs ILMN Comparison

Compare MTSI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MACOM Technology Solutions Holdings Inc.

MTSI

MACOM Technology Solutions Holdings Inc.

HOLD

Current Price

$228.93

Market Cap

18.3B

Sector

Technology

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$124.51

Market Cap

19.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTSI
ILMN
Founded
1950
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
19.0B
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
MTSI
ILMN
Price
$228.93
$124.51
Analyst Decision
Strong Buy
Hold
Analyst Count
9
17
Target Price
$242.89
$124.24
AVG Volume (30 Days)
1.0M
1.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.87
EPS
0.64
5.45
Revenue
$967,258,000.00
$4,343,000,000.00
Revenue This Year
$23.55
$6.54
Revenue Next Year
$17.74
$5.49
P/E Ratio
$382.81
$23.16
Revenue Growth
32.58
N/A
52 Week Low
$84.10
$68.70
52 Week High
$258.98
$155.53

Technical Indicators

Market Signals
Indicator
MTSI
ILMN
Relative Strength Index (RSI) 50.19 49.06
Support Level $203.12 $124.27
Resistance Level $230.82 $126.00
Average True Range (ATR) 10.91 4.43
MACD 1.09 0.75
Stochastic Oscillator 60.91 68.47

Price Performance

Historical Comparison
MTSI
ILMN

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: